Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
nice; BUT - This is something we have known for years. I really mean YEARS!
WHERE are the $, AND what is the schedule to get to the $!!!!?
Great they made a new sign. Let’s put it on the tote bag.
I do not care but size of the tote bag has me on pins and needles.
You think you would have received an email by now as to the event and how it would be available.
Guess they are too busy.
Here is a test for the IR department. Can’t wait.
They, the shorts, have been trapped for years. It is joke at this point.
The stock is 60 cents. Those shorts really put themselves in a bind from $2.50 all the way down to 60 cents.
I feel so sorry for them.
Well then maybe they should have hired more people to actually do the work to get to approvals at a reasonable time frame. How many years after data lock are we at now?
MRK has dedicated people to work on submissions. We have consultants with other jobs and customers. We created our own long term he’ll.
I have probably owned more stock in other biotech companies than many others here.
I love the guys that think they are the only ones with actual knowledge if you disagree with them.
My beef is this company is not run like a public company and shareholders just Linda,Inc. skate. Every year she just skates into the sunset with no accountability to shareholders.
Personnel needed to change after May ten over a year ago.
Sure they are. Every quarterly call by any company starts with the disclaimer that theses are best guess estimates snd may not actually occur as we say.
Every company quarterly call I have ever heard had talked about financials. Burn rate snd what they expect to take in - optimistic and pessimistic range. Also what goals they think they can accomplish.
Every company I have owned small large, biotech or other provides information to shareholders.
Stop with the nonsense that we for some reason are different than any other public company with a duty to shareholders.
They need a 3rd IR guy to get something out.
I do not really expect an answer. This what leadership should be telling analysts and their shareholders.
Great. Another scientific conference. Can anyone remember NWBO attending an investor conference over the last ten years?
Great. Tell me what the stock price will be. All I see now is 60 cents.
$6, $60. $600 …… and let’s assume all 1.7 billion shares.
What would you pay if you were buying a foundational piece for all solid tumor cure?
I am skeptical about mostly everything from this company lately but there is no reason they cannot file for GBM and have another filing for tissue agnostic label. For that matter they could also file at anytime for combinations.
You do not have to go through all the trials. Some are stopped for efficacy and companies file BLAs.
With this leadership team. Which is no leadership but a handful of lawyers, I have zero clue.
You need a leader not afraid to take questions from accredited analysts. You need a leader laying out the $ coming in, going out and expectations.
We do not have that type of leader.
My perspective we are at 60 cents from stupidity.
60 cents is a fact.
When is Bosch’s talk so I can be sure to miss it and speculate what we think they may do at a certain time years from now. Why years? If they say they intend to do something soon, it has always been years if at all.
I have taken a stick in the eye for so long, I really cannot think straight about what I want. All solid tumors. I want a lot more than $10.
I do not think you are correct about what the reasons were about. And what RA requested or how many were involved. No one knows, because we were never told.
Here is one for you. The screening halt that one well known blogger stated the trial was halted. How soon did they respond bo fire losing millions on market cap?
If it was fast you would remember. Even better if they were transparent with shareholders prior there would have been zero misunderstanding.
Tell me when they have fired back fast against any lies put out about them. They lose market cap due to their incredible lightning response.
They had data for 5 years. Bring a lawsuit before such a big day. According to someone posting the other day they had more than 1000 occurrences.
They are always slow, slower, and finally the slowest!
I cannot argue that point.
Unfortunately, $4 is where it should have ended up a year ago on May 10. Welcome to NWBO hell.
He may have his opinion but as a chart reader I would say $4 playing the cup and handle game.
Innes was a huge success over a year ago on May 10. I would have been let go from any job if I performed that poorly.
And I did state it is NOT Theranos. The data is real and viable.
Colon trial in Mainz that were to be paid for by someone else.
Direct trials to start shortly after Bosch’s ASCO presentation a few years ago.
I can go on but you can correct the two I just put out their as not evaporating into thin air without an explanation.
And fu$$ ups are pretty obvious. If anyone considered May 10 over a year ago excellence in Investor Relations they really need to have their head examined.
Was it TLD, it may have been TLD, it wasn’t TLD because the company said nothing. Strong supporters of the company turned themselves into pretzels trying to rationalize their actions. Took weeks to correct publications that got it wrong and have them retract. By then more than half of market cap vanished only to finance with lower valued shares.
If that is success, I need a different definition of the word.
I meant to say they are NOT Theranos.
If the fu$$ ups were not so often, and promises of things to come evaporating into thin air with no explanation, you wouldn’t get the complaints.
The team brings it on themselves. They are Theranos, but the hey are not transparent and have zero accountability. How many years were they on the 1 yard line.
My right to complain because I own shares. For eleven years. I think they are close to finally generating revenue and I think it is a paradigm shift in treatment, but it doesn’t mean I have to like how things have been handled.
So why hire IR people? Take them off the payroll. If you are not going to speak about $, why hire speakers.
If all Innes does is strokes Fife’s as$. Use investment bankers.
Time to speak. Like I said yesterday, saying you will file this year with the RAs is like saying I will be a year older this year. Not useful information.
Ya gotta believe and it ain’t over til it is over.
I believe it ain’t over til it is over.
Just want a f$&?ing clue what decade.
Depends. Is it a platform for all solid cancer or just GBM?
Answer that question for the IP along with what Sawston is worth then you can compute.
I am still thinking platform. If it was just an unapproved GBM drug at the present time with a manufacturing facility, the 60 cents is about it until approval.
But it is way too cheap at 60 cents with no approval if it is the platform.
It wasn’t meant to be short term investment. I knew there were a number of years after all the talk from them on the 1 yard line. Then the crazy lawsuits and poor governance. Include that with the loss of Woodford’s support and avoiding any partnership by management I cannot say it is all my fault.
I think following the look at the blinded data, they should have filed or at least formed a partnership. And if they are not filing for combination or tissue agnostic now it far from my fault.
“If you like ‘long term’ investments NWBO is certainly the right place for you. “
Very funny. When I bought this eleven years ago I thought I would be collecting dividends by now. I feel like I have been divided into smaller and smaller pieces by a samurai master. Linda San.
Ok. Ha. You got me to chuckle.
What would make you feel that way? Do you have a tingle up your leg?
And the most I got from the ASM is they will file strategically either RAs this year. That is about as useful as saying I will be a year older this year.
Our leadership should be controlling the message. That is their job.
Great. Sure excellent work but it is not the Danish Dude’s job. There are 2 IR people employed by the company.
Where are responses by them. It took weeks for Innes to finally get AARC to recant after May 10 over a year ago. This is not competent.
Now. Q2 2023. They are a failure in my book now based on share price. Robert Duvall could do better as CEO. At least he would have name recognition and not be associated with muck.
I think you are wrong. Just a difference of opinion. I cannot see them going another six months without approval from one or two RAs. And considering they talking all cancer at ASCO, they have to be applying for agnostic tissue at least in the UK. Why? Because everyone in management and holding shares will be dead or to infirm to appreciate a successful test in another 15 years for one type of cancer.